Tuna from the Indian and South and East Pacific oceans and New Zealand Hoki, together with marine-farmed Salmon, are intended to provide the initial unrefined oils for processing into high value Omega-3 products.
We expect traceability, freshness and sustainable accreditation of our source fish stocks will continue to rise in importance for our customers as global consumers demand more information, more transparency, more ethical behaviour, and evidence that companies are doing the right thing.
GOED OMEGA-3 EPA + DHA DAILY INTAKE RECOMMENDATIONS
SeaDragon believes the research into Omega-3s is compelling. It supports our drive into the market, especially because we believe, over the long-term, our Omega-3 products can achieve a premium by leveraging New Zealand’s association with clean, pure, fresh and cool, deep blue oceans and its reputation for producing food of the highest quality and purity.
IMPORTANT REMINDERS REGARDING INTAKE
Some governments recommend higher intakes than those listed.6
Intakes can be increased significantly without concern for adverse health effects, according to reports from Spherix7, EFSA88, and Norway’s VKM9.
EPA and DHA Omega-3s are only part of the composition of Omega-3 rich oils (e.g. fish, krill, algal, etc).
For the general healthy adult population, in order to lower the risk of coronary heart disease (CHD).1
For pregnancy / lactation: 200 additional mg/day of DHA over recommendation for healthy adults.2
For secondary prevention of CHD: 1000mg/day EPA + DHA3.3
Higher intakes are supported for a range of additional health conditions (e.g. blood pressure4, triglycerides5).
- International Society for the Study of Fatty acids and Lipids (ISSFAL). Report of the subcommittee on recommendations for intake of polyunsaturated fatty acids in healthy adults [internet]; Washington, DC: ; 2004. Available from http://www.issfal.org/newslinks/resources/publications/PUFAIntakeReccomdFinalReport.pdf
- Koletzko B Cetin I Brenna JT for the Perinatal Lipid Intake Working Group (2007). Dietary fat intakes for pregnant and lactating women. Br J Nutr. 98:873-877.
- Kris-Etherton PM Harris WS and Appel LJ for the American Heart Association Nutrition Committee (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease [published correction appears in Circulation 2003;107:512]. Circulation 106:2747-2757.
- Miller PE Van Elswyk M and Alexander DD (2014). Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomised controlled trials. Am J Hypertens. 27:885-896. http://www.ncbi.nlm.nih. gov/pmc/articles/PMC4054797/pdf/hpu024.pdf
- Eslick GD Howe PR Smith C Preist R and Bensoussan A (2009). Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 136:4-16
- Global Organisation for EPA and DHA Omega-3s. Global recommendations for EPA and DHA intake [Internat]. Salt Lake City: ; 2014. Available from http://geodomega3.com/ files/download/363
- Spherix Consulting, Inc. Hazard characterisation of the long-chain polyunsaturated n-3 fatty acids, DHA [Internet]. Available from http://geodomega3.com/files/download/247. Prepared for the Global Organisation for EPA and DHA Omega-3s.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal [Internet]. 10(7):2815. Available from http://efsa.europa.eu/sites/default/files/scientific_output/files/main_ documents/2815.pdf
- Norwegian Scientific Committee for Food Safety (VKM). Evaluation of negative and positive health effects of n-3 fatty acids as constituents of food supplements and fortified foods [Internet]. Available from: http://www.vkm.no/dav/c7a41adb79.pdf
Omega-2 can be sourced from either animal or vegetable sources and is primarily used in the cosmetics, nutraceutical and pharmaceutical industries and also in high-grade lubrication and fibre coating. SeaDragon produces human consumption grade Omega-2, primarily for the nutraceutical market.
The raw materials for Omega-2 are sourced mainly from deep water dogfish, but also from the liver of the deep sea shark, which forms the richest source of natural squalene. Shark liver oil consists of about 60-85 % of this natural material. By means of comparison olive oil has a squalene concentration of only 0.4 –0.8 %.
Products from our fractionation activities include Squalene >99%, Deep Sea Shark Liver Oil (DSSLO) fractions, Alkoxyglycerols and New Zealand School Shark Liver Oils.
Squalene is a naturally occurring unsaturated hydrocarbon compound found in the livers of deep sea sharks. It also occurs in small quantities in the human body, to help keep the skin moist and supple. Traces are also found in vegetable oils such as olive oil.
Squalene is a strong antioxidant, helping to support oxidative damage from free radicals, which are known to cause degenerative damage to membranes and cells.
Alkoxyglycerols are found in various animal tissues and it has been established that the deep sea dogfish caught in the waters surrounding New Zealand has particularly high levels. These alkoxyglycerols are used in supplement form to support immune health.
DSSLO is sourced from shark species caught in the waters surrounding New Zealand under the QMS system. It is a natural complex mixture of of Squalene (a compound renowned for its natural antioxidant activity) and Diacyl glycerol ethers (DAGE). The oil also has around 15% Triacylglycerols (TAG’s which contain long chain PUFA’s including Omega 3 oils); plus it is a good source of vitamins A, D & E.